IP Library Granted Patent US 6,843,563
Granted Patent B2
US 6,843,563 · App. 10/210,708 · Granted Jan 18, 2005

Smoothly blended optical surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,843,563
App. No.
10/210,708
Granted
Jan 18, 2005
Kind
B2
Abstract

Apparatus, products, and methods are described that relate to blending various disparate optical surfaces in a smooth and continuous manner. In cross section, the two disparate surfaces are represented as meridional profiles. A blend zone profile is described by a single third-order polynomial. In the case of rotationally symmetric optics, one cross-section suffices for the description of the entire surface. In the case of non-rotationally symmetric optics, an increased number of cross-sections are necessary to produce the desired three-dimensional surface, thus meridional profiles are calculated at selected azimuthal locations to describe the full surface.

Claims (803)

1. A contact lens having an anterior surface and a posterior surface, wherein at least one of the surfaces is non-rotationally symmetric, further wherein the non-rotationally symmetric surface has a plurality of disparately shaped, radially adjacent zones, comprising:

a conjoining blend zone having a cross sectional profile defined by a single third-order polynomial.

2. The contact lens of claim 1 , wherein the non-rotationally symmetric surface further comprises a plurality of azimuthally adjacent blend zones to describe a full blend zone surface.

3. The contact lens of claim 2 , comprising a total of 24 blend zones spaced every 15 degrees to describe a full 360 degree blend zone surface.

4. A contact lens having a cross sectional surface profile including a first zone profile and a disparate, second zone profile radially adjacent the first zone profile, comprising a non-correctible blend zone profile that smoothly and continuously joins the first and second zone profiles, wherein the blend zone profile is defined by a single third-order polynomial.

5. The contact lens of claim 4 , comprising a plurality of azimuthally adjacent blend zone profiles to describe a full blend zone surface.

6. The contact lens of claim 5 , comprising 24 blend zone profiles azimuthally spaced in 15 degree increments over a 360 degree surface.

7. A readable medium including a device executable instruction for making, by the device, a smooth and continuous blend zone surface between a first zone surface and a radially adjacent, disparate, second zone surface in an optical lens, to create a smooth, non-rotationally symmetric optical surface, wherein the instruction defines the blend zone surface by a plurality of separate, azimuthally adjacent blend zones each of which has a meridional cross sectional profile defined by a single third-order polynomial of the form

z ( x )= a 1 +a 2 ·x+a 3 ·x 2 +a 4 ·x 3 ,

where z(x) is a sag value over the blend zone profile.

8. The medium of claim 7 , wherein a solution to the equation z(x) for the coefficients an takes the following form:

a

1

=

z

1

·

x

2

3

-

x

1

·

x

2

3

·

m

1

-

x

2

2

·

m

2

·

x

1

2

-

3

·

z

1

·

x

2

2

·

x

1

+

x

1

2

·

x

2

2

·

m

1

+

3

·

z

2

·

x

2

·

x

1

2

+

x

2

·

m

2

·

x

1

3

-

z

2

·

x

1

3

x

2

3

-

3

·

x

1

·

x

2

2

+

3

·

x

2

·

x

1

2

-

x

1

3

a

2

=

x

2

3

·

m

1

+

x

2

2

·

x

1

·

m

1

+

2

·

x

2

2

·

m

2

·

x

1

-

m

2

·

x

2

·

x

1

2

-

2

·

x

1

2

·

x

2

·

m

1

-

6

·

z

2

·

x

2

·

x

1

+

6

·

x

2

·

z

2

·

x

1

-

m

2

·

x

1

3

x

2

3

-

3

·

x

1

·

x

2

2

+

3

·

x

2

·

x

1

2

-

x

1

3

a

3

=

-

2

·

x

2

2

·

m

1

-

x

2

2

·

m

2

+

3

·

z

2

·

x

2

-

3

·

z

1

·

x

2

+

x

1

·

x

2

·

m

1

-

x

2

·

m

2

·

x

1

+

2

·

x

1

2

·

m

2

+

3

·

z

2

·

x

1

-

3

·

z

1

·

x

1

+

x

1

2

·

m

1

(

x

2

-

x

1

)

·

(

x

2

2

-

2

·

x

1

·

x

2

+

x

1

2

)

a

4

=

x

2

·

m

1

+

x

2

·

m

2

+

2

·

z

1

-

x

1

·

m

2

-

x

1

·

m

1

-

2

·

z

2

x

2

3

-

3

·

x

1

·

x

2

2

+

3

·

x

2

·

x

1

2

-

x

1

3

,

where (x 1 , z 1 ) and (x 2 , z 2 ) are the endpoint coordinates and start point coordinates, respectively, of a first meridional cross sectional surface zone profile and a second meridional cross sectional surface zone profile, representative of the first zone surface and the radially adjacent, disparate, second zone surface, and m 1 and m 2 are slope data at (x 1 , z 1 ) and (x 2 , z 2 ).

9. The medium of claim 7 , wherein the device is at least one of a numerically controlled, multi-axis lathe and a laser.

10. A method for designing a non-rotationally symmetric surface for an aberration correcting lens that requires joining at least two radially adjacent, disparate zones to form a smooth and continuous surface, comprising:

determining a smooth and continuous blend path between the at least two zones, wherein the blend path has a meridional cross sectional profile defined by a single third-order polynomial of the form

z ( x )= a 1 +a 2 ·x+a 3 ·x 2 +a 4 ·x 3 ,

where z(x) is a sag value over the blend zone profile.

11. The method of claim 10 , further comprising:

a) obtaining values for x 1 , z 1 , x 2 , z 2 , and m 1 , m 2 for a selected meridian, where (x 1 , z 1 ) and (x 2 , z 2 ) are the endpoint coordinates and start point coordinates, respectively, of the first meridional cross sectional surface zone profile and the second meridional cross sectional surface zone profile, representative of the first zone surface and the radially adjacent, disparate, second zone surface, and m 1 and m 2 are slope data at (x 1 , z 1 ) and (x 2 , z 2 );

b) solving the polynomial equation for the unknown coefficients a n to determine the meridional cross sectional blend zone profile; and

c) repeating steps (a) and (b) for a different selected meridian.

12. The method of claim 11 , wherein a solution for a 1 , a 2 , a 3 , a 4 has the form

a

1

=

z

1

·

x

2

3

-

x

1

·

x

2

3

·

m

1

-

x

2

2

·

m

2

·

x

1

2

-

3

·

z

1

·

x

2

2

·

x

1

+

x

1

2

·

x

2

2

·

m

1

+

3

·

z

2

·

x

2

·

x

1

2

+

x

2

·

m

2

·

x

1

3

-

z

2

·

x

1

3

x

2

3

-

3

·

x

1

·

x

2

2

+

3

·

x

2

·

x

1

2

-

x

1

3

a

2

=

x

2

3

·

m

1

+

x

2

2

·

x

1

·

m

1

+

2

·

x

2

2

·

m

2

·

x

1

-

m

2

·

x

2

·

x

1

2

-

2

·

x

1

2

·

x

2

·

m

1

-

6

·

z

2

·

x

2

·

x

1

+

6

·

x

2

·

z

2

·

x

1

-

m

2

·

x

1

3

x

2

3

-

3

·

x

1

·

x

2

2

+

3

·

x

2

·

x

1

2

-

x

1

3

a

3

=

-

2

·

x

2

2

·

m

1

-

x

2

2

·

m

2

+

3

·

z

2

·

x

2

-

3

·

z

1

·

x

2

+

x

1

·

x

2

·

m

1

-

x

2

·

m

2

·

x

1

+

2

·

x

1

2

·

m

2

+

3

·

z

2

·

x

1

-

3

·

z

1

·

x

1

+

x

1

2

·

m

1

(

x

2

-

x

1

)

·

(

x

2

2

-

2

·

x

1

·

x

2

+

x

1

2

)

a

4

=

x

2

·

m

1

+

x

2

·

m

2

+

2

·

z

1

-

x

1

·

m

2

-

x

1

·

m

1

-

2

·

z

2

x

2

3

-

3

·

x

1

·

x

2

2

+

3

·

x

2

·

x

1

2

-

x

1

3

.

13. A system for making an optical lens having a non-rotationally symmetric surface, comprising:

a device cooperatively engageable with an optical element having a surface intended to be altered to provide an optical aberration correction, said device being suitable for altering the surface of the optical element upon an executable instruction;

a control system operatively associated with the device and adapted to receive a medium including the instruction and to provide the instruction to the device for execution; and

a medium including the executable instruction suitable for reading by the control system and for execution of the instruction by the device,

wherein the instruction instructs the device to make a smooth and continuous blend zone surface profile between a first cross sectional surface profile of the non-rotationally symmetric surface and a radially adjacent, disparate, second cross sectional surface profile of the non-rotationally symmetric surface, wherein the blend zone surface profile is defined by a single third-order polynomial of the form

z ( x )= a 1 +a 2 ·x+a 3 ·x 2 +a 4 ·x 3 ,

where z(x) is a sag value over the blend zone profile.

14. The system of claim 13 , wherein the device is a numerically controlled lathe.

15. The system of claim 13 , wherein the device is a laser.

Assignments (23)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (059913/0548) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072469/0091 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 048556/0758) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 043251/0932) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061872/0099 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 056811/0814) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061872/0669 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 059121/0001) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 031156/0508) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0446 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 034749/0689) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
PATENT SECURITY AGREEMENT Recorded May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Jul 19, 2017
From: BAUSCH & LOMB INCORPORATED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0932 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →